XBiotech (XBIT) Retained Earnings (2014 - 2026)

XBiotech has reported Retained Earnings for 13 years, with the latest figure at -$148.6 million in Q2 2026.

• On a quarterly basis, Retained Earnings fell 43.62% year-over-year to -$148.6 million in Q2 2026; TTM through Jun 2026 was -$148.6 million, a 43.62% decrease from a year earlier, with the FY2025 full-year figure at -$136.4 million, down 50.13% from the prior year.
• Retained Earnings was -$148.6 million for Q2 2026 at XBiotech, down from -$136.4 million in the prior quarter.
• The five-year high for Retained Earnings was $2.1 million in Q1 2022, with the low at -$148.6 million in Q2 2026.
• Average Retained Earnings over 5 years is -$67.2 million, with a median of -$62.3 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Retained Earnings sank 1608.12% in 2023, then slumped 36.3% in 2025.
• Over 5 years, Retained Earnings stood at -$27.7 million in 2022, then tumbled by 88.5% to -$52.3 million in 2023, then sank by 73.66% to -$90.8 million in 2024, then plunged by 50.13% to -$136.4 million in 2025, then slipped by 8.97% to -$148.6 million in 2026.
• The last three Retained Earnings figures came in at -$148.6 million (Q2 2026), -$136.4 million (Q4 2025), and -$109.5 million (Q3 2025), per Business Quant data.